pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    ETX-636
    Human Epidermal Growth Factor Receptor 2 Negative Breast… ENSEM Therapeutics Inc
  • Phase 2
    EU-101
    Colorectal Cancer Eutilex Co Ltd
  • Phase 2
    EVM-14
    Esophageal Squamous Cell Carcinoma (ESCC) Everest Medicines Ltd
  • Phase 2
← prev
page 12 of 50
next →
131
Pain89
Neurology1
EVO-756
Chronic Inducible Urticaria
$EVMN Evommune, Inc.
  • Phase 2
    EVX-01
    Metastatic Melanoma$EVAX Evaxion A/S
  • Phase 2
    EXE-346
    Pouchitis ExeGi Pharma LLC
  • Phase 2
    EXG-34217
    Dyskeratosis Congenita (Zinsser-Cole-Engman Syndrome) Elixirgen Therapeutics Inc
  • Phase 2
    EXT-608
    Hypoparathyroidism Extend Biosciences Inc
  • Phase 2
    EcoActive
    Crohn's Disease (Regional Enteritis) Ferring International Center SA
  • Phase 2
    Elixcyte
    Elixcyte
    Chronic Kidney Disease (Chronic Renal Failure) Unicocell Biomed Co Ltd
  • Phase 2
    F-652
    Alcoholic Hepatitis Evive Biotech
  • Phase 2
    FB-102
    Celiac Disease$FBRX Forte Biosciences, Inc.
  • Phase 2
    FB-825
    Atopic Dermatitis (Atopic Eczema) Oneness Biotech Co Ltd
  • Phase 2
    FB-849
    Solid Tumor 1st Bio Therapeutics Inc
  • Phase 2
    FF-10502-01
    Solid Tumor Fujifilm Holdings Corp
  • Phase 2
    FGF-1
    Coronary Artery Disease (CAD) (Ischemic Heart Disease) Zhittya Genesis Medicine Inc
  • Phase 2
    FKPC-101
    Metastatic Prostate Cancer CellVax Therapeutics Inc
  • Phase 2
    FP-101
    Vasomotor Symptoms of Menopause (Hot Flashes) Fervent Pharmaceuticals LLC
  • Phase 2
    FPI-2265
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Fusion Pharmaceuticals Inc
  • Phase 2
    FWD-1802
    Metastatic Breast Cancer Shenzhen Forward Pharmaceutical Co Ltd
  • Phase 2
    Fancalen
    Fanconi Anemia Centers of Biomedical Research Network
  • Phase 2
    GC-1134A
    Fabry Disease GC Biopharma Corp
  • Phase 2
    GCC-4001
    Idiopathic Inflammatory Myopathy (IIM)$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GD2-SADA-177Lu-Proteus
    Melanoma Y-mAbs Therapeutics Inc
  • Phase 2
    GEOCM-04S1
    Coronavirus Disease 2019 (COVID-19)$GOVX GeoVax Labs, Inc.
  • Phase 2
    GFH-375
    Colorectal Cancer$VSTM Verastem, Inc.
  • Phase 2
    GI-102
    Metastatic Melanoma GI Innovation Co Ltd
  • Phase 2
    GIM-122
    Solid Tumor Georgiamune Inc
  • Phase 2
    GIM-531
    Metastatic Melanoma Georgiamune Inc
  • Phase 2
    GLIX-1
    High-Grade Glioma Tetragon Biosciences Ltd